Study of Anitocabtagene-autoleucel in Relapsed or Refractory Multiple Myeloma (iMMagine-1)

计划入组 136 人 · 首次发布于 2022 年 5 月 31 日

An Observational Study to Validate the Cumulative Life Course Impairment (CLCI) Instrument (DermCLCI-p) in Adult Participants With Moderate to Severe Chronic Plaque Psoriasis (PsO)

计划入组 154 人 · 首次发布于 2023 年 7 月 25 日

Neurobiology of Opioid Dependence: 3 - 3

首次发布于 1999 年 9 月 21 日

Anitocabtagene autoleucel

Oxybenzone(Meijer)

C₁₄H₁₂O₃

BE-3-3-3-3

3-D Matrix Ltd.

Japan

River 3 Renal Corp.

United States

Immuno Cure 3 Limited

Kite and Arcellx to Initiate Phase III Trial of Anito-Cel for Multiple Myeloma

Anitocabtagene Autoleucel Shows Durable Efficacy in Advanced Multiple Myeloma

Anito-cel Shows Promise as Novel BCMA-Targeted CAR T Therapy for Multiple Myeloma